about
sameAs
Histone recognition and large-scale structural analysis of the human bromodomain familyLarge-scale structural analysis of the classical human protein tyrosine phosphatomeOpen access chemical probes for epigenetic targets8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase InhibitorsStructural and Functional Characterization of the Human Protein Kinase ASK1A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesRVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomainStructure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodiesDual kinase-bromodomain inhibitors for rationally designed polypharmacologyComprehensive characterization of the Published Kinase Inhibitor SetDiscovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsTreatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic miceLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorGeneration of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapyThe high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cellsStructure-Based Design of an in Vivo Active Selective BRD9 InhibitorLP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain InhibitorAssessing histone demethylase inhibitors in cells: lessons learned.Targeting the Bromome: are we there yet?Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells.Chemical probes targeting epigenetic proteins: Applications beyond oncology.New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomainsAssessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules.Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk.BET inhibition as a new strategy for the treatment of gastric cancer.Generation and analyses of human synthetic antibody libraries and their application for protein microarrays.The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins.Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.SH2 domains: modulators of nonreceptor tyrosine kinase activity.Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.Targeting kinases for the treatment of inflammatory diseases.Selective targeting of Bromodomains of the Bromodomain-PHD Fingers family impairs osteoclast differentiation.Progress towards a public chemogenomic set for protein kinases and a call for contributions.Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.Frapid: achieving full automation of FRAP for chemical probe validation
P50
Q24310431-BCA0BDC7-7069-47EC-8979-152154D8BBD9Q24321557-85DB5491-F92A-415C-B3BA-D9430CA67D2EQ26781872-E22234E9-BE27-4FEC-8023-4472BA3FA238Q27644640-97ECAC96-1663-4188-9DEE-6C7825B8936FQ27648785-2827A69E-F7D0-4233-B68F-C25C2CDA3971Q27649303-FA6F7A93-C987-4306-A6FA-CDFC6BEF558FQ27680635-95F9B983-F75F-4410-AFF4-B21F894CF59FQ27681380-DA7894FD-E45A-4722-A86D-257AA983C4D8Q27681935-AD637CAD-E7F1-475D-9546-54588A0EA92EQ27702518-B5363357-CB23-4C8C-88C1-B2EB490103AEQ28242369-D07AB471-FA89-4252-95E5-FA6333669D13Q28260292-1C6623A4-A1D3-478B-965F-7408B2763A64Q28260305-B8D64FFD-745F-446E-9D2C-7CDFF4FF3793Q28269627-CC77130D-23E3-4844-85B7-CE1F50B59FC2Q28570659-E212A7D9-714C-4F12-9D60-CB0A8FDC3DC4Q28829832-6379B2BC-058E-4C94-9E2F-12D5BC9DA699Q28834025-EFC258B0-6FF7-4406-804F-E80EE850D2B2Q30361704-468547B8-967D-4DC9-A0D1-067087BC9BAAQ30489777-06D74295-2CB0-499C-9F2B-93787D3B647FQ30668581-AED38409-282A-4DD0-9BBA-F0C570BE4A8FQ33751386-4AD7C24D-E562-4DC2-9BE4-1735439DA2FCQ34334123-D107A908-32A6-44A7-87A1-97A25288C42FQ34338531-E7855CD0-1051-4604-A9F2-0757E518977AQ34390229-5F7E7A9A-1C31-43D5-8293-8AEC36455994Q35220027-0E0400E9-2C86-4728-8C76-D9085D76621AQ35577550-12FCAFB1-9310-4BE2-94EE-1E684DD641E3Q35885359-FD197E54-7B28-4DAD-A5C4-B59772034B38Q36012341-376A46C1-BAB4-4AE3-9B75-027978FCE73AQ36040347-47499193-10CD-4EE6-91AA-11A3C3FF9462Q36122012-F299190E-5BD4-4C83-80C2-356720C5B1FEQ36969182-49F7B75A-4B9C-4618-AC12-577310F16852Q37334404-61F160E0-1F00-4014-91A8-57CB02A3F841Q37635474-1301A58D-B663-4DF9-83AF-A56B76798699Q37691709-A5F977A0-1F2D-4179-B6D2-7AE10F1958F0Q38028572-C95B205D-8499-41F5-9936-751499D37709Q38604141-10E2DD9E-7854-45EF-B17D-41A54C600438Q38646648-F0EF2BA0-0178-485E-830F-583592328497Q38668625-EF14D77E-9E01-422E-90A0-052766CD6CBFQ38668661-8720B2D0-EE22-4093-A27D-CC105FB3C794Q38681544-07ECE1C4-40CF-4BB1-A737-F988B1BEA7A8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Susanne Müller
@ast
Susanne Müller
@en
Susanne Müller
@es
Susanne Müller
@nl
Susanne Müller
@sl
type
label
Susanne Müller
@ast
Susanne Müller
@en
Susanne Müller
@es
Susanne Müller
@nl
Susanne Müller
@sl
altLabel
Müller S
@en
Susanne Muller
@en
Susanne Muller-Knapp
@en
Susanne Müller-Knapp
@en
prefLabel
Susanne Müller
@ast
Susanne Müller
@en
Susanne Müller
@es
Susanne Müller
@nl
Susanne Müller
@sl
P106
P21
P31
P496
0000-0003-2402-4157